2.4 Exposure definition The primary exposure was GLP-1 RA use, defined as any documented prescription fill for a GLP-1 RA (liraglutide, semaglutide, exenatide, and dulaglutide) at least 90 days prior to the index date, based on prescription records in the electronic health record
Siddharth Tambar, a renowned specialist in rheumatology and regenerative medicine, sheds light on the efficacy and duration of Semaglutide (Ozempic and Wegovy) for weight loss
Lets explore what long-term data suggests about semaglutide and gastrointestinal health, and discuss whether users generally develop a tolerance to these effects
FDA Oversight of Compounding The FDA doesnt approve individual compounded medications the way it approves brand-name drugs
Weight appeared to plateau between weeks 40 and 48 for most participants, though 12% continued losing through the studys end